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Summary 
Ligation of the extracellular domain of the cell surface 
receptor FaslAPO-1 (COSS) elicits a characteristic pro- 
grammed death response in susceptible cells. Using a 
genetic selection based on protein-protein interaction 
in yeast, we have identified two gene products that 
associate with the intracellular domain of Fas: Fas it- 
self, and a novel 74 kDa protein we have named RIP, for 
receptor interacting protein. RIP also interacts weakly 
with the ~55 tumor necrosis factor receptor (TNFRl) 
intracellular domain, but not with a mutant version of 
Fas corresponding to the murine /pFg mutation. RIP 
contains an N-terminal region with homology to pro- 
tein klnases and a C-terminal region containing a cyto- 
plasmic motif (death domain) present in the Fas and 
TNFRl intracellular domains. Transient overexpres- 
sion of RIP causes transfected cells to undergo the 
morphological changes characteristic of apoptosis. 
Taken together, these properties indicate that RIP is 
a novel form of apoptosis-inducing protein. 
Although regulated cell death is known to be essential for 
the orderly development of metazoan organisms and is 
crucial to the proper functioning of the immune system 
in higher vertebrates, relatively little is known about the 
mechanisms by which cell death programs are executed. 
One important mediator of immunologically relevant cell 
death processes is the Fas antigen/APO-l (CD95), origi- 
nally identified as the target of monoclonal antibodies that 
could kill multiple cell types (Trauth et al., 1989; Yonehara 
et al., 1989). cDNA cloning and sequence analysis (Itoh 
et al., 1991; Watanabe-Fukunaga et al., 1992a; Oehm et 
al., 1992) showed Fas to be a member of a family of trans- 
membrane receptors that includes the low affinity nerve 
growth factor (NGF) receptor, the tumor necrosis factor 
receptors (TNFRl and TNFRP), and a variety of immune 
cell receptors including CD40, 0X40, CD30, CD27, and 
4-1 BB(forreviewseeSmith et al., 1994). Several members 
of this family besides Fas have been shown to regulate 
or induce cell death, in particular the ~55 TNFR (TNFRl) 
(Tartaglia et al., 1991, 1993b) and the ~75 TNFR (TNFR2) 
(Heller et al., 1992, 1993; Clement and Stamenkovic, 
1994). 
Disruption of Fas expression or function in lymphoproli- 
feration (/or) mutant mice leads to a progressive lymphade- 
nopathy and autoimmune syndrome resembling human 
systemic lupus erythematosus (Watanabe-Fukunaga et al., 
1992b). The residual cytotoxic activity of T cells derived 
from perforin-deficient mice is also dependent on the pres- 
ence of at least one wild-type allele of the Ipr locus (Kagi 
et al., 1994; Kojimaet al., 1994; Lowin et al., 1994). Thus, 
the ability of Fas to induce cell death is important for the 
maintenance of at least two immunological processes in 
vivo: peripheral tolerance to self (Singer and Abbas, 1994; 
Crispe, 1994) and calcium-independent T cell cytotoxicity 
(reviewed by Henkart, 1994). 
The mechanism by which Fas induces cell death is un- 
known, but it requires multivalent cross-linking of the re- 
ceptor (Dhein et al., 1992) and is facilitated by concurrent 
inhibition of RNA or protein synthesis in some cell types. 
Other factors have been reported to modulate Fas activity 
(Klas et al., 1993), and under certain circumstances, Fas 
is capable of signaling activation rather than death 
(Alderson et al., 1993). Anti-Fas antibodies and TNF are 
both capable of signaling cell death in vitro with similar 
kinetics (Yonehara et al., 1989; ltoh and Nagata, 1993) 
and among members of the NGFITNF receptor family, 
Fas and TNFRl share the most significant cytoplasmic 
homology. 
Deletion and mutational analyses have led to the identifi- 
cation of sequences within Fas that are required for the 
cell death response (Itoh and Nagata, 1993). It has been 
proposed that a death domain contained in a region of 
similarity between Fas and TNFRI is essential for the initi- 
ation of apoptosis by both molecules, perhaps through an 
interaction with other intracellular proteins (Tartaglia et al., 
1993a). 
To study the events elicited by Fas ligation, we have 
exploited a yeast protein interaction system to identify a 
novel protein that interacts with the Fas cytoplasmic do- 
main. This protein, which we have named RIP (for receptor 
interacting protein), contains a death domain homology 
region at its C-terminus and a kinase domain at its N-ter- 
minus. Overexpression of RIP leads to morphological 
changes characteristic of apoptosis. The ability of RIP to 
associate with the Fas intracellular domain in yeast and 
to promote apoptotic changes upon overexpression in 
mammalian cells suggests it may be an important element 
in the signal transduction machinery that mediates pro- 
grammed cell death. 
Results 
Identification of cDNAs Encoding Protein 
Domains That Bind Fas 
A cDNA library screen for proteins that interact with the 
intracellular domain of Fas was conducted with the help 
of a yeast genetic selection system (Gyuris et al., 1993; 
Zervos et al., 1993). A cDNA segment comprising virtually 
the entire cytoplasmic domain of human Fas (residues 
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Figure 1. Specificity of RIP Interactions in Yeast 
(A) RIP-Fas and Fas-Fas interactions. Cells of the S. cerevisiae strain 
EGY48lpRB1840 were sequentially transformed with the indicated 
L&&-fusion plasmid and either the Act-Fas or the Act-RIP library 
isolate. Independent colonies arising from the activator plasmid trans- 
formations were streaked on Ura- His Trp- plates containing X-Gal, 
galactose, and raffinose and photographed using a red filter. 
(B) Quantitative P-gal assay. Three colonies from each Act-RIPILexA- 
fusion protein pair were used to inoculate a galactose-containing liquid 
culture. The P-gal activity of lysates prepared from each culture was 
measured and normalized to the total protein concentration of the 
lysate. 5 units (nmoleslminlmg protein) represents the limit of detection 
of b-gal activity in this system. 
(C) Pairwise association between LexA-Fas deletion variants and Act- 
Fas or Act-RIP. The indicated yeast strains were constructed by trans- 
formation, and the production of B-gal was tested by a chromogenic 
colony assay using X-Gal. The extent of color development of individ- 
ual colony streaks was scored visually, with ++++ indicating dark blue 
and - indicating the growth of white colonies only; +I- indicates the 
presence of faint blue flecks in some of the colonies bearing the indi- 
cated AcULexA pair. 
192-329 of the Fas precursor) was fused to the 3’ end of 
the coding region for the bacterial repressor LexA, and a 
yeast expression plasmid containing this gene fusion was 
introduced into a reporter strain harboring the Saccharo- 
myces cerevisiae LEU2 and Escherichia coli P-galactosi- 
dase (B-gal) coding sequences under the control of a syn- 
thetic promoter bearing LexA-binding sites. The resulting 
yeast strain was transformed with a transcriptional activa- 
tor fusion protein library prepared from mRNA isolated 
from the Jurkat (human T cell leukemia) cell line, which is 
known to undergo apoptosis when subjected to treatment 
with anti-Fas antibody. Transformants were plated on se- 
lective (Leu-deficient) plates containing galactose, which 
induces the GAL 7 promoter that directs transcription of the 
library insert. Leu prototrophs were transferred to plates 
containing X-Gal and galactose, and colonies giving a dark 
blue color were recovered and analyzed further. 
To test the specificity of the interaction between the can- 
didate interaction partners and Fas, the library plasmids 
were reintroduced into a second strain harboring a LexA- 
Fas fusion gene (LexA-lpr”g) in which the Fas portion had 
been mutated by substitution of Asn for Val at position 
254 of the Fas precursor sequence. This mutation was 
expected to exhibit a molecular phenotype similar to that 
of the murine /ppg allele, which is formed by substitution 
of Asn for Ile at the homologous position. None of the 
candidate plasmids showing evidence of strong interac- 
tion with LexA-Fas were capable of interacting with LexA- 
Iprcg (Figure 1A; data not shown). 
Restriction site and sequence analysis of the cDNA in- 
serts of the candidate clones showed that they fell into 
only two classes, each of which consisted of an incomplete 
cDNA. One of the inserts encoded the C-terminal residues 
222-335 of the intracellular domain of Fas itself, and the 
other encoded a protein, subsequently named RIP, with- 
out overt relationship to previously described polypep- 
tides. For simplicity in the following discussion, we will 
refer to the transcriptional activator fusion proteins ex- 
pressed by the two classes of library isolates as Act-Fas 
and Act-RIP. 
The specificity of the interaction partners was further 
tested by using the library plasmids to transform yeast 
harboring expression plasmids encoding LexA fusions 
with intracellular domains of various cell surface receptors 
(Figure 1A). Although no interaction was detected in most 
cases (data not shown), weak promoter activity was dis- 
cerned following introduction of the yeast plasmid encod- 
ing Act-RIP into strains harboring LexA-TNFRl intracel- 
lular domain. By contrast, no activity was seen when Act- 
RIP was introduced into strains harboring LexA-TNFR2 
intracellular domain. Yeast transformed with Act-Fas dis- 
played promoter activity in strains harboring LexA-Fas 
intracellular domain, but showed no activity in strains har- 
boring any other LexA-intracellular domain (Figure 1A). 
To measure this effect more precisely, p-gal assays 
were performed on lysates of yeast harboring various pairs 
of LexA-intracellular domain and Act-RIP. Lysates from 
yeast bearing LexA-Fas and Act-RIP contained about 30- 
to 40-fold more P-gal activity than strains bearing Act-RIP 
and either LexA-lpr’gor LexA-TNFR2(Figure 1 B). Lysates 
prepared from yeast harboring LexA-TNFRl and Act-RIP 
expressed S-gal activity at about 10% of the level seen 
in lysates prepared from yeast bearing LexA-Fas and Act- 
RIP (Figure 1 B). 
One explanation for the failure to detect an interaction 
between Act-RIP and LexA-lprcg or LexA-TNFR2 could 
have been that the LexA fusion proteins were poorly ex- 
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Figure 2. Structureof RlPcDNAsand Deduced AminoAcidSequence 
(A) Schematic diagram of RIP cDNA. The inserts of clones isolated 
from a mouse thymus cDNA library are symbolized as lines above a 
bar diagram of the composite sequence, which depicts the regions 
encoding the kinase domain (stippled box), the death domain (closed 
box), and a region of unknown function predicted to have high a-helical 
content (open box). Also shown is the region of human RIP that was 
used as a probe to isolate murine cDNAs. The original human RIP 
isolate encompassed sequences encoding the death domain and 
about 100 residues upstream. 
(6) Inferred polypeptide sequence. The mouse sequence consists of 
a contiguous open reading frame proceeding from a translational initia- 
tion consensus. The human sequence predicted from a cDNA frag- 
ment is shown below the mouse; identical residues are indicated by 
a dash, and gaps indicated by a period. The conserved consensus 
sequences for casein kinase II (S-X-X-E) and CAMP- or cGMP- 
dependent protein kinase (R-X-X-S) are overlined (reviewed by Ken- 
nelly and Krebs, 1991). 
pressed. To address this possibility, a portion of each ly- 
sate used to measure enzyme activity was subjected to 
gel electrophoresis and blot transfer, followed by detection 
with anti-LexA antiserum. LexA fusion proteins of the ap- 
propriate size were detected in each of the lysates, and 
both the LexA-lpr”g and LexA-TNFR2 fusion proteins were 
found to be more abundantly expressed than LexA-Fas 
or LexA-TNFRl (data not shown), making it unlikely that 
failure to detect interaction in vivo could be attributed to 
degradation or inadequate synthesis of the LexA chi- 
meras. 
To localize the sequences in FaslAPO-1 that are respon- 
sible either for self-interaction or for interaction with RIP, 
we prepared a set of LexA-Fas C-terminal deletion chime- 
ras and tested their ability to support interaction with either 
Act-Fas or Act-RIP, as measured by P-gal colony assay 
(Figure 1C). These studies showed that the 16 C-terminal 
residues of Fas are not required for interaction with either 
RIP or Fas itself, but that removal of additional residues 
severely compromises the association with RIP. 
Cloning and Structure of Murine RIP 
Because the RIP cDNA insert identified by genetic selec- 
tion in yeast did not encode an open reading frame bearing 
a consensus translational initiation sequence, additional 
human cDNA libraries were screened by hybridization for 
a full-length clone. None were identified, however, and 
several of the resulting isolates appeared to terminate at 
approximately the same 5’terminus, suggesting that sec- 
ondary structure in the mRNA might have prevented ex- 
tension of the cDNA by reverse transcriptase. Although the 
largest clone spanned approximately 1 kb of sequence, 
preliminary RNA blot hybridizations revealed a transcript 
of approximately 4.2 kb expressed in cell lines of diverse 
provenance, including tumors of lymphoid, hepatic, renal, 
neuronal, cervical, intestinal, muscular, and skeletal origin. 
To isolate a full-length clone, the human RIP coding 
sequence was used to probe a mouse thymus cDNA li- 
brary. Four distinct overlapping clones were identified, 
ranging in size from 1 kb to 2.4 kb, as shown in Figure 
2A. Restriction analysis and sequencing revealed that one 
of these clones, 1112, extended further 5’ than the others. 
The 2.3 kb insert of III2 contains a 1968 nt open reading 
frame beginning with a translational initiation consensus 
sequence (Kozak, 1987) and predicting a polypeptide of 
656 amino acids with a M, of 74,000 (Figure 28). 
The N-terminal region of RIP bears an extended homol- 
ogy to protein kinases that begins a few residues after the 
presumptive initiating Met and extends to the vicinity of 
residue 300. Quantitative sequence comparisons based 
on a word match algorithm (Altschul et al., 1990) predict 
that this domain is most similar overall to the Tyr subclass 
of protein kinases, with the highest relatedness seen to 
the mouse lckgene product (Marth et al., 1985). However, 
in the key subdomains that discriminate most closely be- 
tween Tyr and Ser/Thr substrate specificity, the DLKPEN 
sequence (corresponding to kinase subdomain VI) and 
the GTLYYMAPE sequence (kinase subdomain VIII), RIP 
appears to match the Ser/Thr family consensus (Figure 
3A; Hanks and Lindberg, 1991; Taylor and Radzio- 
Andzelm, 1994). Residues that are conserved in kinases 
of both subclasses (for example, kinase subdomain IX; 
Figure 3A) are also well conserved in RIP. 
The sequence predicted by the longest of the human 
cDNA fragments consists of 375 amino acids correspond- 
ing to the region just C-terminal to the kinase domain of 
murine RIP and shares 67% sequence identity with the 
murine sequence over this length. Within this domain, the 
first 270 amino acids following the kinase domain have 
no striking homology to other proteins, although a small 
subdomain is highly conserved between mouse and hu- 
man proteins (residues 391-427 of the murine sequence) 
and has a relatively high representation of Arg (R), Gln 
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Figure 3. RIP is Similar to Proteins with Kinase 
and Death Domains 
(A) Comparison of RIP to the catalytic domains 
of Ser/Thr and Tyr kinases and the Src subfam- 
ily of Tyr kinases (sTyr). Consensus sequences 
were described by Hanks and Lindberg (1991) 
and represent analysis of 70 SeVThr kinases, 
26 Tyr kinases, and 6 sTyr kinases. Consensus 
residues found in over 95% of sequences ana- 
lyzed are bolded. 
(B) Sequence alignment of the RIP C-terminus 
with the death domains and C-termini of Fas 
and TNFRl. Gaps are indicated by dashes. 
Consensus residues conserved in all six se- 
quences are capitalized, whereas positions at 
which a charge-conserved residue is found in 
one of the sequences are shown in lower case. 
Noteworthy charge conservations are bolded. 
The regions denoted (A) and (B) represent two 
portions of the Fas cytoplasmic domain com- 
pletely conserved between mouse and human. 
(C?), and Glu (E) (18/37 residues in both sequences). The 
sequence of this region is similar to portions of the tricho- 
hyalin family of hair structural proteins, which contain 
WE-rich repeats that form highly stabilized a helices (Lee 
et al., 1993). 
The RIP C-Terminus Has Death Domain Homology 
The 98 C-terminal amino acids of RIP share 87% se- 
quence identity between mouse and human, suggesting 
they subserve some regulatory function (Figure 2B). Com- 
parable domains of approximately 90 residues close to 
the C-termini of Fas and TNFRl have been shown to play 
a role in the transduction of apoptotic signals to receptive 
cells and have been termed death domains for this reason 
(Tartagliaet al., 1993a). Pairwisecomparisonsof thedeath 
domain sequences aligned in Figure 38 showed the high- 
est relatedness between human RIP and human TNFRl 
(59% similarity and 30% identity), which are significantly 
more similar than human Fas and human TNFRl (42% 
similarity and 23Yo identity). The interspecies conserva- 
tion of the RIP death domain (84% identity between mouse 
and human) exceeds that of the TNFRl (68% identity) and 
Fas (49% identity) death domains. 
Constitutive and Inducible Expression of RIP mRNA 
Preliminary RNA blot hybridization experiments demon- 
strated the existence of an RNA species of approximately 
3.8 kb in a variety of cell lines. To more precisely assess 
mRNA abundance in tissues, a quantitative ribonuclease 
protection assay was employed. Use of a labeled anti- 
sense RNA probe corresponding to the 3’terminus of the 
cDNA gave rise to a ribonuclease-resistant species of the 
expected size in all adult tissues tested (Figure 4A). An in 
vitro labeled RNA antisense to the mRNA for the ribosomal 
large subunit protein L32 was used as an internal standard 
to allow normalization to the amount of RNA loaded in 
each lane. Analysis of the protected RNA showed that RIP 
mRNA levels varied by less than 2-to 3-fold between most 
tissues (data not shown); lung showed the highest expres- 
sion, whereas tongue showed the least. 
The possibility that RIP mRNA might be regulated as a 
consequence of activation in T cells was also explored. 
Dissociated murine splenocytes were stimulated in vitro 
with the lectin-concanavalin A (ConA), and total RNA 
prepared at various times following addition of lectin was 
analyzed for the presence of RIP sequences by RNA blot 
analysis. Little or no RIP RNA could be detected in unstim- 
ulated splenocytes, but a single 3.8 kb species appeared 
in unfractionated splenocytes that had been exposed to 
lectin for 2 hr or longer (Figure 48). Since RIP mRNA is 
detectable by ribonuclease protection in the spleen as a 
whole (Figure 4A), the inability to detect RIP mRNA in 
splenocytes treated with ConAfor less than 2 hr is probably 
due to the lower sensitivity of RNA blot analysis, although 
this discrepancy could also have resulted from RIP expres- 
sion exclusively in the fibrous tissue of the spleen. 
A Polypeptide of the Expected Molecular Mass 
Is Expressed In Vivo 
To examine the distribution of RIP protein in vivo, a rabbit 
antiserum was prepared against a fusion protein con- 
sisting of the 250 C-terminal residues of murine RIP fused 
to E. coli maltose-binding protein. The antiserum specific- 
ity was validated by immunoprecipitation of RIP synthe- 
sized in vitro. Following in vitro transcription and transla- 
tion of the RIP open reading frame, a single labeled 
product of approximately 74 kDa was observed that could 
be specifically immunoprecipitated with the rabbit antise- 
rum, but not with serum from unimmunized animals (Fig- 
ures 5A and 58). The specificity of the antiserum for RIP 
was alsodocumented by its inability to immunoprecipitate 
an irrelevant protein (Photinus pyralis luciferase) similarly 
translated in vitro. lmmunoprecipitation of a lysate of meta- 
bolically labeled NIH 3T3 cells with the rabbit antiserum 
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Figure 4. RIP Expression 
(A) RNase protection analysis of total RNA harvested from adult tis- 
sues Each RNA (10 pg) was incubated with labeled antisense RNAs 
complementary to the 3’ end of the RIP cDNA sequence and to se- 
quences within the mRNA for the ribosomal large subunit protein L32 
(normalization control). Following digestion of the unhybridized RNA, 
the protected fragments were separated on a 6% denaturing polyacryl- 
amide gel. tRNA (50 pg) was substituted for the sample RNA to assess 
the adequacy of RNase digestion. 
(6) T cell activation induces RIP mRNA. An RNA blot prepared from 
8 ag samples of total RNA from splenocytes treated with ConA for the 
indicated period of time was hybridized with labeled RIP cDNA or a 285 
rDNA probe and washed as described in the Experimental Procedures. 
revealed the presence of a single protein species with the 
same molecular mass as that revealed by in vitro transla- 
tion of RIP (Figure 5C). 
Detection of RIP in Transiently Transfected 
BHK Cells 
To determine whether RIP protein could have a direct ef- 
fect on cell viability, BHK cells grown on coverslips were 
transiently transfected with an epitope-tagged version of 
RIP (RIP-Myc) and reacted with anti-RIP antiserum or an 
anti-Myc monoclonal antibody. Weak expression was de- 
tected with both antibodies. The pattern of immunoreactiv- 
ity was heterogeneous, with both diffuse cytoplasmic as 
well as punctate perinuclear patterns observed (Figures 
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Figure 5. lmmunoprecipitation of RIP 
(A) An insert fragment from RIP cDNA clone III2 was transcribed and 
translated in vitro, and the reaction products were analyzed on a 10% 
SDS-polyacrylamide gel. Included as controls were samples in which 
either no RNA, or an RNA encoding P. pyralis luciferase, was trans- 
lated. 
(B) lmmunoprecipitation of the in vitro translation products of (A) with 
an antiserum raised against the C-terminus of RIP, or with preimmune 
serum. 
(C) lmmunoprecipitation of an [%]Met-labeled lysate of NIH 3T3 cells 
with the antiserum described in (8). 
6A and 6B). DNA staining with Hoechst 33256 showed 
that many of the RIP-expressing cells had apoptotic nuclei, 
a feature not seen when vector or Fas control expression 
plasmids were used (data not shown). However, a number 
of RIP-expressing cells could be found that had normal- 
appearing nuclei; conversely, apoptotic cells having no 
detectable RIP staining were also seen. 
The concordance of cell death and RIP expression sug- 
gested the ability to detect RIP-Myc protein might be com- 
promised by the death of the cells in which it was being 
expressed. To test this and the possible role of individual 
RIP domains in apoptosis, two additional epitope-tagged 
constructs were prepared: one lacking C-terminal se- 
quences, including the death domain (RIP-MycAdeath), 
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Figure 8. RIP lmmunofluorescence 
BHK cells were transiently transfected with 
plasmids expressing RIP-Myc (A-C), RIP- 
MycAkinase (D-F), or RIP-MycAdeath (G-H) 
and reacted with anti-Myc monoclonal antibod- 
ies (A, D, and G), anti-RIP polyclonal antibodies 
(Band E), or Hoechst 33258(C, F, and H). Cells 
transfected with RIP-MycAdeath plasmid did not 
react with anti-RIP antisera (data not shown). 
and one lacking - 200 amino acids in the kinase domain 
(RIP-MycAkinase). Both deletion mutants showed greater 
immunoreactivity with anti-Myc antibodies (Figures 6D 
and 6G) than the full-length construct. Only RIP- 
MycAkinase was detected by the anti-RIP antiserum (Fig- 
ure 6E), as expected from the deletion of its epitope from 
RIP-MycAdeath. 
RIP Overexpression Leads to Cell Death 
To determine whether RIP was inducing cell death, we 
marked the transfected cells by cotransfection with P-gal. 
Cells were transfected with pairs of expression plasmids 
encoding RIP-Myc and p-gal (Price et al., 1987) at a 1:3 
ratio of P-gal plasmid to RIP plasmid. After histochemical 
detection of P-gal activity, cells transfected with S-gal and 
RIP-Myc expression plasmids were found to contain a 
large proportion of intensely staining, shrunken blue cells 
that exhibited membrane blebbing and loss of adherence 
(Figures 7A and 7E). By contrast, transfection with P-gal, 
either alone (Figure 7D) or in combination with RIP- 
MycAdeath (Figure 7C), had no adverse effect upon nu- 
clear morphology and resulted in a predominantly cyto- 
plasmic P-gal staining pattern. Cotransfection of P-gal with 
RIP-MycAkinase likewise gave cytoplasmic staining of 
healthy-appearing cells, although a number of shrunken, 
blebbed cells were also seen (Figure 7B). 
To quantitate these results, cells from three independent 
transfections were examined, and the morphologically 
apoptotic blue cells were enumerated as a fraction of total 
blue cells (Table 1). Over 57% of blue cells arising from 
cotransfection of RIP-Myc and the P-gal showed morpho- 
logical changes consistent with apoptosis, whereas only 
l%-2% of blue cells that had been transfected with P-gal 
plasmid or in combination with RIP-MycAdeath exhibited 
such a phenotype. However, a consistent frequency of 
apoptotic changes was seen in cotransfections involving 
RIP-MycAkinase, with almost 11% of the blue cells ap- 
pearing to have undergone cell death. The fraction of cells 
showing morphological changes was positively correlated 
with the ratio of RIP-Myc or RIP-MycAkinase plasmid to 
P-gal plasmid, so that increasing RIP$-gal plasmid ratios 
gave higher percentages of dead blue cells (data not 
shown). 
Additional transfection experiments were performed us- 
ing cells derived from the human embryonic kidney 293 
cell line (Pear et al., 1993). As with the previous assay, 
cell death was observed in these cells when either the 
RIP-Mycor RIP-MycAkinase plasmid was used. DNAfrag- 
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Figure 7. Apoptotic Changes in Cells Transfected with RIP and 6-Gal 
Expression Plasmids 
BHK cells were transfected on coverslips, fixed after 12 hr, and incu- 
bated in a buffer containing X-Gal to visualize B-gal activity. Transfec- 
tiOnS were carried out with plasmids encoding: (A) RIP-Myc and P-gal, 
(B) RIP-MycAkinase and P-gal, (C) RIP-MycAdeath and B-gal, or (D) 
B-gal alone. (E) Higher magnification of cells shown in (A). 
mentation, a hallmark of apoptotic cell death, was de- 
tected in situ in cells transfected with these plasmids using 
the method of TdT-mediated dUTP-biotin nick end label- 
ing (TUNEL; Gavrieli et al., 1992); no significant cell death 
or DNA fragmentation was observed with the RIP- 
MycAdeath or vector plasmids (data not shown). 
In this study, a genetic selection in yeast for proteins capa- 
ble of interacting with the intracellular domain of Fasl 
APO-l identified cDNAs encoding two proteins from a hu- 
man T cell cDNA library: Fas itself and a novel kinase- 
related protein, RIP, containing a death domain. Neither 
protein interacts with a humanized variant of the murine 
/pr”g allele, a point mutant that confers much the same 
phenotype on affected mice as does the original Ipr allele 
(Matsuzawa et al., 1990). The finding that the intracellular 
domain of the /pP variant is incapable of interacting with 
the wild-type Fas cytoplasmic domain in yeast suggests 
that oligomerization of Fas mediated by cytoplasmic se- 
quences may be a prerequisite for activity. However, it 
has not been established whether oligomerization of Fas 
is necessary for interaction with RIP, or whether the same 
subdomain exploited for oligomerization is also required 
for heteromeric association with RIP. The discovery of the 
Fas-Fas interaction in a library screen is consistent with 
a recent demonstration that TNFRl and Fas are capable 
of both self- and cross-association in yeast (Boldin et al., 
Table 1. Quantitation of RIP-Induced Cell Death 
Percent Dead f SEM 
Construct (number of cells scored) 
RIP-Myc plus b-gal 57.3 + 1.7 (616) 
RIP-MycAkinase plus t3-gal 10.9 f 1.1 (660) 
RIP-MycAdeath plus B-gal 2.0 + 0.7 (661) 
6-gal alone 1.6 f 0.2 (639) 
The cotransfections described in Figure 7 were repeated in triplicate, 
and the cells were fixed and analyzed for lacZ expression 16 hr after 
transfection as detailed in the Experimental Procedures. The data are 
expressed as the mean percentage of blue cells exhibiting signs of 
apoptosis as a fraction of the total number of blue cells counted (shown 
in parentheses). 
1995). In accord with the notion that the death domain 
may itself mediate such interactions, we find here that RIP 
can also associate with the intracellular domain of TNFRl. 
Despite conservation of sequence, structure, and func- 
tion between Fas and TNFRl , downstream effects of the 
two receptors have been dissociated in some cell types 
(Wong and Goeddel, 1994; Schulze-Osthoff et al., 1994), 
whereas responses in other cells suggest that elements 
of their signaling pathways may be shared (Clement and 
Stamenkovic, 1994; Schulze-Osthoff et al., 1994). The 
finding that RIP interacts with both Fas and TNFRl in 
yeast is attractive for its intimation of a simple explanation 
for the shared manifestations of receptor ligation. 
Deletion analysis of Fas has previously demonstrated 
that the 15 C-terminal amino acids are not required for 
signaling, but that larger deletions abolish the ability of 
Fas to induce apoptosis (Itoh and Nagata, 1993). Consis- 
tent with these findings, this study has shown that in yeast 
RIP binds well to a Fas molecule lacking the 16 C-terminal 
amino acids, but that larger deletions of the Fas cyto- 
plasmic domain greatly reduce or abolish this interaction. 
The human RIP fragment identified by yeast interaction 
was used to clone a murine cDNA that appears to span 
the entire coding region. The authentic 5’ and 3’ ends of 
the RIP mRNA have yet to be defined, however. Sequenc- 
ing of the 3’ends of cDNA clones 1111, 1112, and I1 b yielded 
about 1.4 kb of putative untranslated sequence includ- 
ing an AAUAAA transcription termination signal, but no 
poly(A) tail (data not shown). Genomic sequence obtained 
from the S’end suggests the presence of at least one more 
noncoding 5’ exon (data not shown). Of the discrepancy 
between the 3.4 kb of identified sequence and the approxi- 
mately 3.6 kb of RNA identified in blot hybridization experi- 
ments, the fraction that can be attributed to poly(A) is un- 
certain. 
RIP mRNA is expressed at low levels in all tissues. A 
pattern of widespread expression has also been observed 
for Fas (Leithauser et al., 1993; B. Z. S. and P. L., unpub- 
lished data), although in contrast with RIP, fas mRNA is 
found at higher levels in thymus, liver, lung, and heart. 
Like fas mRNA, RIP mRNA is induced in splenocytes after 
activation with ConA. Although a requirement for RIP in 
Fas-mediated killing has not been established, coordinate 
induction of Fas and RIP may contribute to increased sus- 
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ceptibility of T cells to Fas-mediated cell death following 
activation (Owen-Schaub et al., 1992). 
The N-terminus of RIP has strong homology to kinases 
of both SerIlhr and Tyr kinase subfamilies. In the two 
interacting loops that appear to control hydroxyamino acid 
recognition (Hubbard et al., 1994; Taylor and Radzio- 
Andzelm, 1994), RIP closely resembles a Ser/Thr kinase. 
In particular, it lacks the Ala-X-Arg or Arg-X-Ala motif 
in subdomain VI and the Pro-X-X-Trp motif in subdomain 
VIII that closely correlate with Tyr substrate specificity 
(Hanks et al., 1986). However, among sequences avail- 
able at the time of submission, RIP shows the greatest 
global similarity to murine Ick, a Tyr kinase of the Src fam- 
ily. The relatedness to Tyr kinases is especially apparent 
among the framework residues outside the putative active 
site. For example, RIP has a tryptophan at position 269 
that is present in all Tyr kinases analyzed by Hanks and 
Quinn (1991), but absent from all Ser/Thr kinases exam- 
ined except Mos. The presence of structural motifs from 
both Tyr and Ser/lhr kinases has also been noted for the 
soybean kinase GmPK6 (Feng et al., 1993), with which 
RIP shares high global similarity. RIP contains a small 
number of amino acids that differ from the conserved resi- 
dues of either Ser/Thr or Tyr kinases, for example a Gly 
at position 24 that is present in the majority of kinases from 
both classes. However, at residues that are conserved in 
all protein kinases, RIP follows the consensus. 
We have found that overexpression of RIP results in the 
induction of a cell death program morphologically similar 
to apoptosis. Deletion of the C-terminal region of RIP span- 
ning the segment of death domain homology eliminated 
the apoptotic response, but deletion of the kinase domain 
did not entirely quench activity. It may be that the overex- 
pression of the death domain itself is lethal to transfected 
cells, consistent with the observation by Boldin et al. (1995) 
that expression of the free intracellular domain of TNFRl 
has a cytocidal effect on HeLa cells. The induction of 
apoptosis by transient transfection suggests that the level 
of expression or ability of death domain-bearing proteins 
to self-associate may be subject to some form of regulation 
to prevent the spontaneous initiation of apoptosis in the 
absence of ligand or other eliciting stimulus. 
The notion that a stoichiometrically limiting intracellular 
effector is involved in the pathway of Fas-mediated apop- 
tosis is supported by the recent demonstration that maxi- 
mal signaling by Fas and the TNF receptors requires an 
intermediate level of receptor cell surface expression 
(Clement and Stamenkovic, 1994). This result is consis- 
tent with a model in which the initiation of signal transduc- 
tion is critically dependent on the aggregation-mediated 
focal accumulation of a limiting cytoplasmic ligand, which 
can be diluted to the point of inefficacy by overexpression 
of the cell surface receptor. The data presented here that 
RIP is not encoded by a highly expressed RNA, but that 
the transcript accumulates rapidly in response to T cell 
activation, in turn admits the possibility that RIP may be 
limiting for receptor-mediated apoptosis. However, other 
factors may also interact with the Fas intracellu!ar domain, 
as suggested by the findings that Fas can transmit activa- 
tion as well as death signals (Alderson et al., 1993). 
Still unclear is the mechanism by which formation of a 
multimeric Fas complex would result in signal transduc- 
tion. Although enzymatic activity has not been demon- 
strated for RIP, the possibility that it encodes a protein 
kinase is attractive given the proposed participation of 
at least one Tyr kinase in Fas signaling (Eischen et al., 
1994). However, results with the mutant plasmid RIP- 
MycAkinase suggest thar any kinase potential RIP has 
may not be required for its induction of cell death. 
In preliminary experiments, a monoclonal antibody rec- 
ognizing murine Fas has been found to specifically coim- 
munoprecipitate a polypeptide of about 59 kDa that reacts 
with anti-RIP antiserum (data not shown). This 59 kDa 
protein may represent a proteolytic fragment of RIP or a 
related protein that is recognized by anti-RIP antibodies. 
Although the evidence that RIP binds to Fas in yeast favors 
a model in which RIP acts directly downstream of Fas in 
a death pathway, it is also possible that RIP has other 
actions, or that the normal physiological role of the mole- 
cule lies in a pathway initiated by other cues. The creation 
of mice or cell lines homozygously deficient in RIP should 
help to address this point. In addition, the elucidation of 
any target(s) of action of RIP may also facilitate our under- 
standing of the role(s) RIP plays in the cell death response. 
Experimental Procedures 
Plasmid Construction 
The yeast interaction system was modified from that described by 
Gyuris et al. (1993) by engineering the LexA expression plasmid to 
remove an internal Mlul site and to insert Mlul and Not1 sites down- 
stream from the DNA portion encoding the C-terminus of the gene. 
The resulting distal polylinker has the site sequence Mlul-Pmel-Notl- 
EcoRl in the frame in which the Mlul site encodes Thr and Arg (frame 
1). Complete sequences are available from the authors (B. S.) upon 
request. 
Receptor cytoplasmic tails were amplified by PCR from cDNA librar- 
ies and cloned as Mlul-Not1 or BssHII-Not1 fragments using the follow- 
ing oligos: Fas, 5’-CGC GGG ACG CGT AAG GAA GTA CAG AAA 
ACA TGCJ’ and 5’-CGC GGG GCG GCC GCT CTA GAC CAA GCT 
TTG GAT I-X-3’; TNFRl, 5’ CGC GGG GCG CGC TAC CAA CGG 
TGG AAG TCC AAG-3’ and 5’ CGC GGG GCG GCC GCT GCC CGC 
AGG GGC GCA GCC TCA-3’; TNFRZ, 5’-CGC GGG ACG CGT AAG 
AAG CCC lTG TGC CTG CAG-3’ and 5’-CGC GGG GCG GCC GCT 
lTA ACT GGG Cl7 CAT CCC AGC-3’. The Fas cytoplasmic domain 
used in the library screen diverges at the Glu 5 residues prior to the 
C-terminus and continues an additional 25 residues through vector 
sequences to the C-terminus. In all subsequent analysis, these resi- 
dues were found not to contribute detectably to either Fas-Fas or Fas- 
RIP interaction. A mutant Fas bait protein analogous to the /pp point 
mutation was made by mutating the Val at position 254 of human 
Fas to Asn using the following oligos in a recombinant PCR reaction: 
5’-CGA AAG AAT GGT AAC AAT GAA GCC-3’ and 5’-GGC TTC Al7 
GlT ACC Al7 CTT TCGJ’. In the resulting construct, residues 330 
and 331 were also converted from Glu and Ile to Gly and Asn, respec- 
tively. Fas deletion mutants were made by PCR with the Fas 5’ oligo 
and 3’oligos substituting a stop codon for the amino acid at the indi- 
cated position; products were subcloned in!o the LexA expression 
plasmid as described above. Oligos used were the following: (S320’) 
5’~CGC GGG GCG GCC GCT TTA AGT AAT GTC CTT GAG GAT 
GAT-3’; (K299’) ?I’-CGC GGG GCG GCC GCT TTA GAG ATC l-l-T 
AAT CAA TGT GTC-3’; (H265’) 5’-CGC GGG GCG GCC GCT TTA 
AAG TTG ATG CCA ATT ACG AAG-3’; (K263’) 5’CGC GGG GCG 
GCC GCT TTA GAT CTC ATC TAT l-IT GGC -lTC-3’. 
A Myc-tagged version of RIP (RIP-Myc) was made by digesting RIP 
clone III2 with Tfil and ligating a Hindlll-Tfil adaptor to the B’end and 
a Tfil-Notl adaptor containing the Myc epitope and a stop codon to 
the 3’end. The sense (145) and antisense (146) oligonucleotides com- 
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prising the 3’ adaptor were as follows: 145, 5’-ATT CGT GCC AGC 
CAG AGC GGC ATG GAG CAG AAG CTC ATC TCA GAA GAA GAC 
CTC GCG TAA GC-3’ and 146, 5’-GGC CGC TTA CGC GAG GTC 
TTC l-K TGA GAT GAG CT-T CTG CTC CAT GCC GCT CTG GCT 
GGC ACG-3’. The resulting insert was cloned into the Hindlll and 
Notl sites of pcDNA I (Invitrogen). To make RIP-MycAkinase, a PCR 
reaction was performed using a 5’ RIP primer (160, 5’CCC AAG CTT 
GTT GGA GAT TCT GAG CAA TC-3’) and an internal kinase domain 
primer (161, B’CCC GAT CTG CAG GTC ATG TAA GTA GCA CAT 
GCC-3’). The resulting product was cloned into the Hindlll and Pstl 
sites of RIP-Myc resulting in the deletion of RIP residues 132-323. 
RIP-MycAdeath was made by PCR using a T7 primer and a Myc tag- 
containing primer (151, 5’CCC CTC GAG TTA GAG GTC TTC TTC 
TGA GAT GAG CTT TTG CTC TlT ClT TAA ACT TGC CAC-3’). The 
amplified RIP-MycAdeath sequence, lacking amino acids 309-656, 
was subcloned as a Hindlll-Xhol fragment into pcDNA I. Myc tags 
were located at the C-terminus of all proteins, and thus, detection of 
the Myc epitope requires translation of the entire cloned sequence. 
The BAG retrovirus vector encoding p-gal has been described (Price 
et al., 1967). 
Yeast Strains and Library Screen 
Yeast transformation with library DNA was performed by the method of 
Schiestl and Gietz (1989) as follows,Recipient cells, EGY48/pRBl840 
(Gyuris et al., 1993) bearing LexA-fusion protein plasmids, were grown 
overnight in YPAD medium to a density of approximately lO’cells/ml, 
then diluted in 100 ml of warmed YPAD to a density of 2 x 108 cells/ 
ml and regrown to IO’ cells/ml. The cells were harvested and washed 
in water, resuspended in 1 ml of water, transferred to a sterile microcen- 
trifuge tube, and pelleted. The pellet was resuspended in 0.5 ml of 
IO mM Tris-HCI (pH 7.5) 1 mM EDTA, 0.1 M Li acetate (pH adjusted 
to 7.5 with acetic acid and passed through 0.2 u filter). 50 ul of the 
resulting suspension was mixed with 1 pg of transforming DNA and 
50 ug of single-stranded salmon sperm DNA, after which 0.3 ml of a 
solution of 40% polyethylene glycol-4000 in Tris, EDTA, LiOAc was 
added and mixed thoroughly, followed by incubation at 30°C with 
agitation for 30 min. After a heat pulse at 42OC for 15 min, the cells 
were pelleted in a microcentrifuge, and the pellets were resuspended 
in 1 ml of Tris, EDTA, diluted, and plated on selective medium. Library 
screening and recovery of plasmids were performed as described by 
Gyuris et al. (1993). 
For assessing the interaction of RIP and Fas with other bait proteins, 
cells of the yeast strain EGY48/pSHl6-34 were transformed with the 
indicated bait construct and selected on Ura- His- glucose plates, 
These bait strains were subsequently used for transformation of the 
RIP or Fas library plasmids and plated on Ura- His- Trp- glucose 
plates. Several colonies from each baitlinteractor combination were 
picked and plated in duplicate on Ura- His- Trp- X-Gal plates con- 
taining either 2% glucose or 2% galactose, 1% raffinose. The LexA- 
TNFRP bait strain gave a weak blue color reaction when grown on 
galactose, indicating spontaneous transcriptional activation by the fu- 
sion protein. 
B-Gal Assays 
Assays of crude extracts were carried out as described (Rose et al., 
1990). Cells bearing the appropriate bait and interaction plasmid were 
grown to saturation overnight at 30°C in minimal Ura- His- Trp- me- 
dium with 2% glucose. The next day, cells were diluted I:50 into me- 
dium containing 2% galactose and 2% raffinose and allowed to grow 
overnight. Cells were spun and resuspended in breaking buffer (100 
mM Tris [pH 61, 20% glycerol [v/v], 1 mM DTT). Cells were lysed in 
the presence of 10 mM PMSF by vortexing with acid-washed beads. 
Lysates were cleared by centrifugation, and an aliquot was incubated 
in 2 buffer (Miller, 1972) with 0.67 mglml o-nitrophenyl+D-galactoside 
substrate. Reactions were stopped with Na2C03 when an appropriate 
level of color had developed. Protein concentrations were determined 
by Bradford assay. B-Gal units were calculated by the equation: spe- 
cific activity (nmoleslminlmg) = (OD1,. 378)/(time [min].vol [ml].con- 
centration [mglml]). 
cDNA Cloning 
Additional clones overlapping the primary RIP isolate were sought in 
two libraries: an expression library prepared in the CDM8 plasmid 
vector using mRNA isolated from the human cytolytic T cell line WH3 
and a commercially available human leukocyte library in A. phage pur- 
chased from Clontech (HLl ISSa). Both libraries were screened by 
filter replica hybridization, using radiolabeled probes derived from the 
insert isolated by interaction screening, as well as from subsequent 
inserts identified by hybridization. 
To isolate murine RIP cDNA clones, 1.2 kb of human RIP sequence 
was subcloned into two halves and radiolabeled using the random 
hexamer method (Feinberg and Vogelstein, 1983). An oligo(dT)- 
primed mouse thymus cDNA library from a (C57B1/6 x CBA)Fl mouse 
(Stratagene) was plated out and I@ plaques werescreened using each 
of the human fragments on duplicate GeneScreen filters (DuPont). 
Hybridization conditions were 5 x SSPE, 10x Denhardts. 2% SDS, 
0.1 mg/ml herring sperm DNA at 55’C overnight. Filters were washed 
in 2 x SSC, 0.1% SDS at 55OC with several changes over 1 hr. Plaque 
purified phage were isolated with three roundsof screening (Sambrook 
et al., 1989) and in vivo excision was carried out using Exassist phage 
and SOLR recipient cells (Stratagene). Seven independent clones 
were isolated that fell into the four classes in Figure 2A. The coding 
sequence of RIP was obtained as a composite from the cDNA clones 
sequenced on both strands using Sequenase T7 polymerase (United 
States Biochemical). Several nucleotide polymorphisms were da 
tected between the multiple clones, only one of which resulted in an 
amino acid difference: a Thr to Ile at position 473. Sequence compari- 
sons were done with Genetics Computer Group, Inc. or MegAlign 
(DNAStar, Inc.) software using default parameters. 
RNase Protections and RNA Blot Hybrldlzation 
Tissue RNA samples were prepared from wild-type FVB mice (Taconic) 
by guanidinium thiocyanate lysis and centrifugation through a CsCl 
cushion (Chirgwin et al., 1979). An antisense probe for RIP made 
from cDNA clone Ill1 linearized with Spel was synthesized using T7 
polymerase with an in vitro transcription kit (Stratagene), with the addi- 
tion of 20 nM cold rUTP and 100 pCi (SP]UTP (New England Nuclear). 
The ribosomal L32 probe was synthesized from an Xbal-linearized 
template at 10% the specific activity of the RIP probe. The use of L32 
as an internal control for RNA loading has been described elsewhere 
(Shen and Leder, 1992). The in vitro transcription products were 
slightly larger than the protected fragments of 525 nt and 279 nt, re- 
spectively, as expected. RNase protection was carried out as de- 
scribed by Melton et al. (1984). 
For measuring RIP in activated T cells, spleens were removed from 
adult animals and dissociated using a stainless steel mesh. Cells 
(-10’ per timepoint) were exposed to ConA (IO uglml) for O-4.5 hr, 
and RNA was prepared as described above. Approximately 8 ug of 
total RNA from each sample was loaded on a 0.9% agarose, 4% 
formaldehyde gel, electrophoresed, and transferred to nylon filters 
(GeneScreen, DuPont) by capillary transfer (Sambrook et al., 1989). 
The blot was hybridized with either an RIP probe corresponding to 
the C-terminal half of the protein (cDNA 1111) or with a probe detecting 
ribosomal 28s RNA and incubated overnight in 40% formamide, 4x 
SSC, 10% dextran sulfate, 7 mM Tris (pH 7.6) and 20 uglml salmon 
sperm DNA at 42°C. Blots were washed at 50°C in 1 x SSC, 0.1% 
SDS (RIP probe) or 60°C in 0.1 x SSC, 0.1% SDS (28s probe). 
RIP Antisera and lmmunopreclpitations 
Rabbit polyclonal antisera recognizing RIP were prepared by Pocono 
Rabbit Farm and Laboratory, Inc. using a fusion protein containing 
the C-terminal 250 amino acids of mouse RIP fused to maltose-binding 
protein (MBP; New England Biolabs). MEP-RIP was purified by amy 
lose chromatography and acrylamide gel elution. For immunoprecipi- 
tations, RIP was first transcribed in vitro using 15 ug of full-length RIP 
template in a reaction containing 3.3 mM each ATP, GTP, CTP, and 
UTP, 280 U of RNase inhibitor, 400 U of Sp6 RNA polymerase, and 
1 x Sp6 buffer (Boehringer Mannheim Biochemicals). Translations 
were carried out using a reticulocyte lysate kit containing a luciferase 
positive control (Promega) using approximately4 uCi [“S]Met per reac- 
tion. Reaction products were diluted to 1 ml in a modified RIPA buffer 
(0.5% NP40, 0.5% sodium deoxycholate, 0.025% SDS, 50 mM Tris, 
30 mM sodium pyrophosphate, 50 mM NaF, 100 uM sodium orthovana- 
date [pH 7.61) containing protease inhibitors and precleared with nor- 
mal rabbit serum and protein A-Sepharose. Reactions were split in 
half, 5 nl of preimmune or immune serum was added, and samples 
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were allowed to rotate for 1 hr at 4%. Complexes were precipitated 
with 40 ~1 of protein A-Sepharose (1:l). washed with modified RIPA 
buffer, and resolved by SDS-PAGE. 
For immunoprecipitation from metabolically labeled cells, a 150 mm 
plate of subconfluent NIH 3T3 cells was incubated overnight in Met- 
deficient DMEM (GIBCOIBRL) supplemented with [“.S]Met (- 100 pCi/ 
ml), 5% dialyzed fetal calf serum, 2 mM glutamine, penicillin (50 UI 
ml), and streptomycin (50 pglml). Cells were lysed for 15 min on ice 
in lysis buffer (250 mM NaCI, 50 mM HEPES-KOH, [pH 7.51, 5 mM 
EDTA, 0.1 mM sodium orthovanadate, 50 mM NaF, 0.1% Triton-X, 
100 Kg/ml PMSF, 2 pglml pepstatin, and IO pglml each aprotonin and 
leupeptin), scraped, and spun at 15,000 x g for 10 min. Cleared lysate 
was precleared as above, followed by addition of antibodies (3 ul of 
preimmune or immune rabbit serum). Immune complexes were har- 
vested with protein A-Sepharose, and beads were washed with lysis 
buffer before resuspension in denaturing sample buffer. Following 
SDS-PAGE, thegel wasenhanced with enlightening solution (DuPont) 
and dried for autoradiography. 
Transfections and lmmunofluorescence 
BHK cells were plated the night before transfection at a density of lo4 
cells per 18 mm round coverslip (VWR Scientific). CaP04 precipitates 
were made, and cells were reacted with antibodies for immunofluores- 
cence as described by Heald et al. (1993). In most cases, cells were 
analyzed 18-20 hr after transfection. The 9ElO anti-Myc antibody 
(Evan et al., 1985) was obtained as an ascites from the Harvard Cell 
Culture facility and used at 20 pglml. RIP antiserum was used at a 
dilution of 1:200. FITC anti-mouse and Texas red anti-rabbit secondary 
antibodies were obtained from Jackson Immunoresearch. Cells were 
examined with a Zeiss Axiophot fluorescent microscope. 
p-Gal activity in cells was visualized by fixing cells with 0.5% glutar- 
aldehyde for 15 min followed by extensive washing in PBS with 5 mM 
MgCI,. Cells were stained in PBS containing 20 mM each kFe(CN)B 
and K4Fe(CN),.3H20, 1 mM MgC12, and 1 mglml X-Gal (5.bromo-4- 
chloro-Mndolyl-g-D-galactopyranoside) until a suitable color devel- 
oped, usually for 2-3 hr. To enumerate the fraction of blue cells that 
had undergone apoptotic changes, cells were transfected with one of 
the four plasmid combinations described and fixed 16 hr after transfec- 
tion. Blue cells were included for analysis only if their morphological 
status could be scored unambiguously. 
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